case_images: PMC10859240_01
case_images: Exanthematous rash comprising papules, hyperpigmentation mostly on the extensor aspect of proximal and distal inter-phalangeal joints, intertriginous spaces and mild localized erythema.
case_images: cureus-0016-00000052185-i01.jpg
case_images: PMC10859240_01_cureus-0016-00000052185-i01.jpg
case_images: FIG1
case_images: Upon examination, an exanthematous rash comprising papules, hyperpigmentation mostly on the extensor aspect of proximal and distal inter-phalangeal joints, and mild localized erythema was observed, as illustrated in Figure 1. The patient noted the rash and its associated itching subsided within two weeks following the complete cessation of desvenlafaxine (Figure 2, Table 1).
case_images: Two weeks after complete cessation of desvenlafaxine.
case_images: cureus-0016-00000052185-i02.jpg
case_images: PMC10859240_01_cureus-0016-00000052185-i02.jpg
case_images: FIG2
case_images: The patient noted the rash and its associated itching subsided within two weeks following the complete cessation of desvenlafaxine (Figure 2, Table 1).